Reports by Industry
Reports by Company
- Company Analysis(173)
- Company Profile(60)
US Biodefense Market Outlook 2022
Format : 
Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Nov, 2016| No. of Pages : 45
Please make your selection :
Electronic Access - Single User License
US$ 1000.00
CD-ROM Mail Delivery
US$ 1100.00
Hard Copy Mail Delivery
US$ 1100.00
Electronic Access - Multi-User License
US$ 1500.00
1. Analyst View
2. Research Methodology
3. BioDefense - An Introduction
4. Global BioDefense Industry
5. BioDefense Industry Market Outlook to 2022
5.1 Anthrax
5.2 Small Pox
5.3 Botulism
5.4 Radiation
6. Industry Drivers
6.1 Innovative Technology Advancing the BioDefense Industry
6.2 Government Initiatives Contributing to BioDefense Infrastructure
6.3 Research and Development Enhancing Drug Efficiency
7. Industry Roadblocks
7.1 Biological threat detection: A National Challenge
7.2 Stringent Norms: Barriers to Clinical Testing
8. Regulatory Framework
9. Competitive Landscape
9.1 PharmAthene, Inc.
9.1.1 Business Description
9.1.2 Financial Overview
9.2 Emergent BioSolutions
9.2.1 Business Description
9.2.2 Financial Overview
9.2.3 Recent Developments
9.3 Dynavax Technologies Corporation
9.3.1 Business Description
9.3.2 Financial Overview
9.4 SIGA Technologies, Inc.
9.4.1 Business Description
9.4.2 Financial Overview
9.4.3 Recent Developments
9.5 Alnylam Pharmaceuticals, Inc.
9.5.1 Business Description
9.5.2 Financial Overview
9.5.3 Recent Developments
9.6 Cleveland Biolabs, Inc.
9.6.1 Business Description
9.6.2 Financial Overview
Not able to find data you are looking for? Ask our Research Analyst.
media citation
- testtest
19 Jan, 2024 - Yourstory.com News @ Foodtech startup Swiggy launches Health Hub in Chennai
23 Mar, 2021 - Yourstory.com News @ Zomato forays into dietary supplements, makes its own 'made in India' brand
16 Mar, 2021 - View more
get in touch
Copyright © 2018, RNCOS, 2002-2018
About Us
Terms & Policy
Contact